Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy

Journal of Clinical Oncology

Volumn 26, Issue 1, 2008, Pages 112-120

  Moinpour, Carol M ^a   Hayden, Katherine A ^a   Unger, Joseph M ^a   Thompson Jr , Ian M ^a   Redman, Mary W ^a   Canby Hagino, Edith D ^a   Higgins, Betsy A ^a   Sullivan, Jerry W ^a   Lemmon, Dianne ^a   Breslin, Sheila ^a   Crawford, E David ^a  

^a SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; EMOTION; ENTEROPATHY; ERECTILE DYSFUNCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLLAKISURIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE;

AGED; COMBINED MODALITY THERAPY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME;

EID: 37849036818     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.4505     Document Type: Article

References (50)

1. National Institutes of Health Consensus Development Panel: National Institutes of Health Consensus Development Conference Statement on Clinically Localized Prostate Cancer (June 15-17, 1988). Bethesda, MD, National Institutes of Health Government Printing Office, 1988
2. Halperin E, Fraser R, Hughes J: The management of clinically localized prostate cancer: A summary of the Consensus Statement of the National Institutes of Health. N C Med J 49:75-79, 1988
3. Formenti SC, Lieskovsky G, Simoneau AR, et al: Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. J Urol 155:616-619, 1996
4. Van Cangh P, Richard F, Lorge F, et al: Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: Results of a prospective randomized study. J Urol 159:164-166, 1998
5. Bolla M, van Poppel H, Collette L, et al: Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 366:572-578, 2005
6. Fitzpatrick JM, Kirby JS, Krane RJ, et al: Sexual dysfunction associated with the management of prostate cancer. Eur Urol 33:513-522, 1998
7. Davidson BJ, Keyes M, Elliott S, et al: Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapy. BJU Int 93:965-969, 2004
8. Haas GP: Strategies to manage prostate cancer. J Urol 155:628-629, 1996
9. Thompson IM Jr, Tangen CM, Paradelo J, et al: Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA 296:2329-2335, 2006
10. Moinpour CM, Feigl P, Metch B, et al: Quality of life end points in cancer clinical trials: Review and recommendations. J Natl Cancer Inst 81:485-495, 1989
11. Moinpour C, Donaldson G, Padilla G, et al: English and Spanish versions of the Southwest Oncology Group (SWOG) Quality of Life (QOL) Questionnaire: Validation of a total score. Qual Life Res 7:638-639, 1998
12. Moinpour CM, Donaldson G, Padilla G, et al: Health-Related quality of life (HRQL) correlates of perceived overall health in Spanish and English breast cancer populations. Qual Life Res 9:250, 2000 (abstr 1759)
13. Moinpour CM, Hayden KA, Thompson IM, et al: Quality of life assessment in Southwest Oncology Group trials, in Tchekmedyian NS, Cella DF (eds): Quality of Life in Oncology Practice and Research. Williston Park, NY, Dominus Publishing Co, 1991, pp 43-49
14. Moinpour CM, Savage M, Hayden KA, et al: Quality of life assessment in cancer clinical trials, in Dimsdale JE, Baum A (eds): Quality of Life in Behavioral Medicine Research. Hillsdale, NJ, Lawrence Erlbaum Associates, 1995, pp 79-95
15. Moinpour CM, Savage MJ, Troxel A, et al: Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial. J Natl Cancer Inst 90:1537-1544, 1998
16. Moinpour CM, Sawyers TJ, McKnight B, et al: Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial. Psychooncology 9:340-354, 2000
17. Hayden K, Moinpour C, Metch B, et al: Pitfalls in quality-of-life assessment: Lessons from a Southwest Oncology Group breast cancer clinical trial. Oncol Nurs Forum 20:1415-1419, 1993
18. Loll L, Moinpour C, Feigl P: Southwest Oncology Group (SWOG). J Natl Cancer Inst Monogr 20:83-85, 1996
19. Moinpour CM, Lovato LC: Ensuring the quality of quality of life data: The Southwest Oncology Group experience. Stat Med 17:641-651, 1998
20. Stewart AL, Hays RD, Ware JE Jr: The MOS Short-form General Health Survey: Reliability and validity in a patient population. Med Care 26:724-735, 1988
21. Ware JE Jr, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30: 473-483, 1992
22. McCorkle R, Young K: Development of a symptom distress scale. Cancer Nurs 1:373-378, 1978
23. Young KJ, Longman AJ: Quality of life and persons with melanoma: A pilot study. Cancer Nurs 6:219-225, 1983
24. McCorkle R, Benoliel JQ: Symptom distress, current concerns, and mood disturbance after diagnosis of life threatening disease. Soc Sci Med 17:431-438, 1983
25. McCorkle R: The measurement of symptom distress. Semin Oncol Nurs 3:248-256, 1987
26. McCorkle R, Benoliel J, Donaldson G, et al: A randomized clinical trial of home nursing care for lung cancer patients. Cancer 64:1375-1382, 1989
27. McCorkle R, Cooley ME, Shea JA: A User's Manual for the Symptom Distress Scale. Philadelphia, PA, University of Pennsylvania School of Nursing, 1998
28. Kucuk O, Fisher E, Moinpour CM, et al: Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: A Southwest Oncology Group study (SWOG 9235). Urology 58:53-58, 2001
29. Rodriquez FR, Thompson IM, Corrie D, et al: Radical retropubic prostatectomy: A quality of life survey. 36th Annual James C. Kimbrough Urological Seminar, Norfolk, Virginia, October 31-November 4, 1988 (abstr)
30. Selby P, Chapman J-A, Etazadi-Amoli J, et al: The development of a method for assessing the quality of life of cancer patients. Br J Cancer 50:13-22, 1984
31. Selby P, Campbell J, Chapman J, et al: Measurement of the quality of life in patients with breast cancer. Rev Endocr Rel Cancer Suppl 14:245-247, 1984
32. Stewart AL, Greenfield S, Hays RD, et al: Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study. JAMA 262:907-913, 1989
33. McHorney CA, Ware JE Jr, Lu RJF, et al: The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40-46, 1994
34. Sloan JA, Loprinzi CL, Kuross SA, et al: Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 16:3662-3673, 1998
35. Ware JE Jr: Monitoring and evaluating health services. Med Care 23:705-709, 1985
36. Hopwood P, Stephens R, Machin D: Approaches to the analysis of quality of life data: Experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 3:339-352, 1994
37. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 73:13-22, 1986
38. Laird NM, Ware JH: Random-effects models for lungitudinal data. Biometrics 38:963-974, 1982
39. Hamilton AS, Stanford JL, Gilliland FD, et al: Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes Study. J Clin Oncol 19:2517-2526, 2001
40. Penson D, Feng Z, Kuniyuki A, et al: General quality of life 2 years following treatment for prostate cancer: What influences outcomes? Results from the Prostate Cancer Outcomes study. J Clin Oncol 21:1147-1154, 2003
41. Efficace F, Bottomley A, van Andel G: Health related quality of life in prostate carcinoma: A systematic review of randomized controlled trials. Cancer 97:377-388, 2003
42. Rosen RC, Riley A, Wagner G, et al: The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 49:822-830, 1997
43. Ries LAG, Melbert D, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2004. Bethesda, MD, National Cancer Institute, 2007
44. Litwin MS, Hays RD, Fink A, et al: Quality of life outcomes in men treated for localized prostate cancer. JAMA 273:129-135, 1995
45. Lubeck D, Litwin M, Henning J, et al: Changes in health-related quality of life in the first year after treatment for prostate cancer: Results from CaPSURE. Urology 53:180-186, 1999
46. Potosky A, Legler J, Albertsen P, et al: Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the prostate cancer outcomes study. J Natl Cancer Inst 92:1582-1592, 2000
47. Knight S, Siston A, Slimack N, et al: Racial differences in quality of life among veterans with localized prostate cancer. Proc Am Soc Clin Oncol 19:442a, 2000 (abstr 1735)
48. Knight SJ, Latini DM, Hart SL, et al: Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: A longitudinal quality of life analysis from CaPSURE. Cancer 109:1769-1776, 2007
49. Eton DT, Lepore SJ, Helgesen VS: Early quality of life in patients with localized prostate carcinoma: An examination of treatment-related, demographic, and psychosocial factors. Cancer 92:1451-1459, 2001
50. Penson D: The effect of erectile dysfunction on quality of life following treatment for localized prostate cancer. Rev Urol 3:113-119, 2001